Article Details
Retrieved on: 2023-11-20 18:31:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Anthos Therapeutics, Inc. recently announced positive primary data from the AZALEA-TIMI 71 study of patients with atrial fibrillation at ...
Article found on: www.docwirenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here